Search Results - "Guiu, M"

Refine Results
  1. 1

    The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21 by Soria-Valles, C, Gutiérrez-Fernández, A, Guiu, M, Mari, B, Fueyo, A, Gomis, R R, López-Otín, C

    Published in Oncogene (05-06-2014)
    “…Matrix metalloproteinases (MMPs) have been traditionally implicated in cancer progression because of their ability to degrade the extracellular matrix…”
    Get full text
    Journal Article
  2. 2

    Retrospective analysis of venlafaxine-induced hypoglycemia in patients with overdose by Gomila Muñiz, Isabel, Socias Crespí, Lorenzo, Puiguriguer Ferrando, Jordi, Guiu Marti, Alexandra M, Elorza Guerrero, Miguel Ángel, Barceló Martín, Bernardino

    Published in Medicina clinica (12-04-2024)
    “…Recent publications relate the presence of hypoglycemia in venlafaxine (VLX) poisoning depending on the dose. Our aim was to analyze the clinical…”
    Get more information
    Journal Article
  3. 3

    Accuracy-based learning classifier systems: models, analysis and applications to classification tasks by Bernadó-Mansilla, Ester, Garrell-Guiu, Josep M

    Published in Evolutionary computation (01-09-2003)
    “…Recently, Learning Classifier Systems (LCS) and particularly XCS have arisen as promising methods for classification tasks and data mining. This paper…”
    Get more information
    Journal Article
  4. 4

    Quality assessment of buffy-coat-derived leucodepleted platelet concentrates in PAS-plasma, prepared by the OrbiSac or TACSI automated system by Plaza, E. M., Céspedes, P., Fernández, H., Sánchez-Guiu, M. I., Egea, J. M., Vicente, V., Lozano, M. L., Rivera, J.

    Published in Vox sanguinis (01-01-2014)
    “…Background and Objectives Buffy‐coat (BC)‐derived platelet concentrates (PCs) are the predominant product for platelet transfusion in many countries. Two…”
    Get full text
    Journal Article
  5. 5

    Advancing Hospital Pharmacy Practice Through New Competences in Advanced Therapy Medicinal Products by Segura, Josep M. Guiu

    “…[...]the implementation of ATMPs represents new strategic opportunities for hospital pharmacy development, such as ATMP noncommercial bioproduction, quality…”
    Get full text
    Journal Article
  6. 6

    An atypical IgM class platelet cold agglutinin induces GPVI-dependent aggregation of human platelets by Sánchez Guiu, I M, Martínez-Martinez, I, Martínez, C, Navarro-Fernandez, J, García-Candel, F, Ferrer-Marín, F, Vicente, V, Watson, S P, Andrews, R K, Gardiner, E E, Lozano, M L, Rivera, J

    Published in Thrombosis and haemostasis (01-08-2015)
    “…Platelet cold agglutinins (PCA) cause pseudothrombocytopenia, spurious thrombocytopenia due to ex vivo platelet clumping, complicating clinical diagnosis, but…”
    Get more information
    Journal Article
  7. 7
  8. 8

    The KRAS mutation detection within the initial management of patients with metastatic colorectal cancer: A status report in France in 2011 by Lièvre, A, Artru, P, Guiu, M, Laurent-Puig, P, Merlin, J.L, Sabourin, J.C, Viguier, J, Bastie, A, Seronde, A, Ducreux, M

    Published in European journal of cancer (1990) (01-06-2013)
    “…Abstract Background The detection of KRAS mutations is mandatory to initiate an anti-epidermal growth factor receptor (EGFR) antibody in the treatment of…”
    Get full text
    Journal Article
  9. 9

    The enigma of quaternary prevention in Primary Care. When and when not to do it (presentation of two cases) by Cucalón, J M, Guiu, M

    Published in Semergen, medicina de familia (01-09-2013)
    “…Quaternary prevention has been commonly defined with the "primum non nocere" of classical texts by many authors. The daily life of our primary care…”
    Get full text
    Journal Article
  10. 10

    A scoping review of the role of managed entry agreements in upcoming drugs for amyotrophic lateral sclerosis: learning from the case of spinal muscular atrophy by García-Parra, Beliu, Guiu, Josep M, Povedano, MÓnica, Modamio, Pilar

    “…: The therapeutic options for spinal muscular atrophy (SMA) are encouraging. However, there is currently no cure for amyotrophic lateral sclerosis (ALS). The…”
    Get full text
    Journal Article
  11. 11

    PO-184 Role of ubiquitin-conjugating enzymes in chromosome instability and breast cancer metastasis by Salvador, F, Cejalvo, JM, Guiu, M, Fernández, E, Paré, L, Prat, A, Gomis, RR

    Published in ESMO open (01-07-2018)
    “…IntroductionChromosome Instability (CIN) is a hallmark in cancer being aneuploidy found in most of the tumours. In addition, high levels of CIN in primary…”
    Get full text
    Journal Article
  12. 12

    Geographical distribution of clinical trials in amyotrophic lateral sclerosis: a scoping review by García-Parra, Beliu, Guiu, Josep M, Povedano, Mónica, Mariño, Eduardo L, Modamio, Pilar

    “…: Clinical trials location is determined by many factors, including the availability of patient populations, regulatory environment, scientific expertise, and…”
    Get full text
    Journal Article
  13. 13

    The Effect of the Drug-Related Problems Prevention Bundle on Early Readmissions in Patients From the Emergency Department: A Randomized Clinical Trial by Juanes, Ana, Ruíz, Jesús, Puig, Mireia, Blázquez, Marta, Gilabert, Antoni, López, Laia, Baena, M. Isabel, Guiu, Josep M., Antònia Mangues, Maria

    Published in The Annals of pharmacotherapy (01-09-2023)
    “…Background: Drug-related problems (DRPs) are prevalent and avoidable disease that patients experience due to drug use or nonuse. However, secondary prevention…”
    Get full text
    Journal Article
  14. 14

    Cooperativismo agroalimentario en Europa. Dimensión, gobernanza y análisis BCG de las sociedades cooperativas TOP25 de la UE-28 y TOP10 en España by Colom Gorgues, Antonio, Cos Sánchez, Pilar, Florensa Guiu, Rosa M.

    “…Este trabajo tiene por objeto analizar la situación del cooperativismo agroalimentario en Europa, para identificar las estrategias comunes aparecidas en los…”
    Get full text
    Journal Article
  15. 15

    2SPD-010 Review of the environmental criteria introduced in the tendering of drugs, medical devices and non-medical equipment in a health group procurement organisation by Garcia López, V, Moratalla Rolanía, A, Hors Comadira, P, Guiu Segura, JM

    “…Background and ImportanceGreen public procurement is a process of contracting products, services, and works with the least possible damage to the environment…”
    Get full text
    Journal Article
  16. 16

    Access to orphan drugs for the treatment of spinal muscular atrophy in Spain by García-Parra, B, Guiu, J M, Modamio, P, Martínez-Yélamos, A, Mariño-Hernández, E L, Povedano, M

    Published in Revista de neurologiá (01-11-2022)
    “…Spinal muscular atrophy (SMA) is a rare disease whose diagnosis and treatment are complex. In Spain, there are two orphan medicines that are currently financed…”
    Get full text
    Journal Article
  17. 17

    Integrating clinical, molecular, proteomic and histopathological data within the tissue context: tissunomics by Ramón y Cajal, Santiago, Hümmer, Stefan, Peg, Vicente, Guiu, Xavier M, De Torres, Inés, Castellvi, Josep, Martinez‐Saez, Elena, Hernandez‐Losa, Javier

    Published in Histopathology (01-07-2019)
    “…Malignant tumours show a marked degree of morphological, molecular and proteomic heterogeneity. This variability is closely related to microenvironmental…”
    Get full text
    Journal Article
  18. 18

    El enigma de la prevención cuaternaria en atención primaria. Cuándo hacer y cuándo no hacer (a propósito de 2 casos) by Cucalón, J.M, Guiu, M

    Published in Semergen, medicina de familia (01-09-2013)
    “…Resumen La prevención cuaternaria ha sido definida comúnmente con el «primun non nocere» de los textos clásicos por muchos autores. El día a día de nuestras…”
    Get full text
    Journal Article
  19. 19

    2SPD-027 Multi-criteria decision analysis for evaluating new medicines in health technology assessment framework analysis by Torres-Novellas, M, Guiu Segura, JM, Lastra, CF, Mariño, EL, Modamio, P

    “…BackgroundEscalating medicine prices have catalysed the generation of numerous ‘value frameworks’ with the aim of informing payers, clinicians and patients on…”
    Get full text
    Journal Article
  20. 20

    4CPS-146 Sublingual and enteric tacrolimus whole blood levels in an intensive care unit by Doménech, L, Guiu Segura, JM, Montoro Ronsano, JB

    “…BackgroundTacrolimus is an immunosuppressive agent with a narrow therapeutic range (5–15 ng/ml for solid organ transplants). Achieving and maintaining…”
    Get full text
    Journal Article